NAMS MENOPAUSE CERTIFICATION
EXAM QUESTIONS AND ANSWERS
WITH 117 QUESTIONS AND AND
CORRECT ANSWERS RATED A+
2026/2027
Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment
Bisphosphonates.
Recommended daily calcium intake for women aged 51-70 years
1200 mg
Median age of natural menopause
51 years
Characteristic hormonal change in menopause transition
Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan
Osteoporosis
Gabapentin
Improves sleep and reduces hot flashes in menopausal women.
T-score of -2.8 on DEXA scan
Hormone therapy
Hormone therapy regimen for postmenopausal woman with intact uterus
, Estrogen plus progestogen
Recommended treatment for hot flashes in breast cancer survivor
Paroxetine
Contraindication for systemic hormone therapy
Unexplained vaginal bleeding
Non-hormonal medication effective for menopausal sleep disturbances
Gabapentin
Primary risk factor for osteoporosis in postmenopausal women
.
Medication that reduces fracture risk and breast cancer risk
Raloxifene.
Cardiovascular risk factor that increases significantly after menopause
Coronary artery disease.
Contributing factor to elevated LDL cholesterol post-menopause
Estrogen decline.
Common metabolic change in postmenopausal women
Increased visceral fat.
Most effective intervention to reduce cardiovascular risk in postmenopausal
women
Lifestyle modification.
Best approach for a woman on HT asking about cardiovascular safety
Use lowest effective dose.
Most common symptom of genitourinary syndrome of menopause (GSM)
Vaginal dryness.
First-line treatment for vaginal atrophy in postmenopausal women
EXAM QUESTIONS AND ANSWERS
WITH 117 QUESTIONS AND AND
CORRECT ANSWERS RATED A+
2026/2027
Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment
Bisphosphonates.
Recommended daily calcium intake for women aged 51-70 years
1200 mg
Median age of natural menopause
51 years
Characteristic hormonal change in menopause transition
Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan
Osteoporosis
Gabapentin
Improves sleep and reduces hot flashes in menopausal women.
T-score of -2.8 on DEXA scan
Hormone therapy
Hormone therapy regimen for postmenopausal woman with intact uterus
, Estrogen plus progestogen
Recommended treatment for hot flashes in breast cancer survivor
Paroxetine
Contraindication for systemic hormone therapy
Unexplained vaginal bleeding
Non-hormonal medication effective for menopausal sleep disturbances
Gabapentin
Primary risk factor for osteoporosis in postmenopausal women
.
Medication that reduces fracture risk and breast cancer risk
Raloxifene.
Cardiovascular risk factor that increases significantly after menopause
Coronary artery disease.
Contributing factor to elevated LDL cholesterol post-menopause
Estrogen decline.
Common metabolic change in postmenopausal women
Increased visceral fat.
Most effective intervention to reduce cardiovascular risk in postmenopausal
women
Lifestyle modification.
Best approach for a woman on HT asking about cardiovascular safety
Use lowest effective dose.
Most common symptom of genitourinary syndrome of menopause (GSM)
Vaginal dryness.
First-line treatment for vaginal atrophy in postmenopausal women
